Skip to main content
Signal8

Kester Kent Edward

SEC insider (Form 3/4/5 filer). CIK 0002087469. Director at Turn Therapeutics Inc. (TTRX). 2 reported Form 4/5 transactions since Sep 2024; latest on Jun 4, 2026. Located in WESTLAKE VILLAGE, CA.

Companies Kester Kent Edward has filed insider reports for

  • Turn Therapeutics Inc. (TTRX): Director
Kester Kent Edward profile photo

Kester Kent Edward

CIK: 0002087469

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Turn Therapeutics Inc. logo
TTRX

Turn Therapeutics Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Turn Therapeutics Inc. logo
    TTRX

    Turn Therapeutics Inc.

    Jun 4, 2026
    Award

    Stock option (right to buy)

    Direct
    83.3K shares-
  • Turn Therapeutics Inc. logo
    TTRX

    Turn Therapeutics Inc.

    Oct 8, 2025
    Award
    Direct
    10K shares-

1-2 of 2